Skip to main content

Diabetes Device News

Diabetes Devices monitor and help to manage your blood sugar levels to try to stay within the target range, helping prevent complications of diabetes.

BGM    CGM     Injection Pens     Insulin Pumps      AID

Join diaTribe at the American Diabetes Association's 83rd scientific conference for insights on future diabetes care, medication, and the latest tech. Plus, explore...
Medications like aspirin, Tylenol, and vitamin C can potentially impact the accuracy of continuous glucose monitors (CGMs). Here are steps to ensure reliable diabetes...
UnitedHealthcare begins coverage for CGM in people with type 2 diabetes.
In case you missed them, here are our top stories from May 2023. This month’s best stories cover a wide variety of topics like upcoming therapies, new research findings...
Non-invasive glucose monitoring technology has been a dream of people with diabetes for years. Get the latest update on the research and development of these devices.
The National Institute of Clinical Excellence recently announced it was the first to expand access to automated glucose monitors for children with type 2 diabetes. The...
Beta Bionics has received FDA clearance for its insulin-only iLet Bionic Pancreas, an automated insulin delivery system that eliminates the need for carbohydrate...
Participate in Omada Health's 6-month online study for type 2 diabetes management. Earn up to $250, experience their program, and contribute to diabetes research – all...
In a recent study, results showed that improved access to CGM can lower A1C levels in Hispanic children. However, broader societal strategies are needed to address...
Glucomate can help people with type 1 diabetes identify trends in their glucose levels, view historical data, and make better decisions about managing their diabetes.
The FDA has cleared the Omnipod GO: a discreet, water-resistant insulin pod with up to 3 days of wear. Enjoy the freedom and convenience to manage your diabetes.
An analysis shows Tandem’s Control-IQ automated insulin delivery system boosts time in range by three hours per day, largely due to the system's auto-correction feature.
On April 16, Medicare began covering people with type 2 diabetes for continuous glucose monitors (CGMs).
From reducing single-use plastics to supporting companies that prioritize sustainability, there are many ways we can make a difference. Celebrate Earth Day by taking a...
A number of Libre users reported that their reader's lithium-ion battery swelled, overheated, sparked, and in rare cases, caught fire. In response, Abbott has issued a...
Diabetes is a growing health challenge in India, and with limited resources, innovative solutions are needed to improve management and outcomes.
Might there be a way to detect and prevent the serious complication of diabetic ketoacidosis (DKA) before it happens?
Tandem Diabetes announced clinical trial results that showed from the very first day, children with type 1 diabetes who used the Control-IQ hybrid closed loop technology...
How does technology shape the experiences of those with diabetes? From access to healthcare to data collection, the advances of the digital age have left a significant...
The FDA has cleared Abbott's Freestyle Libre 2 and Libre 3 continuous glucose monitors (CGM) for integration with automated insulin delivery (AID) systems. These devices...

Pages